An Extension Study to Further Evaluate the Safety, Tolerability of GBT440 in Patients With Sickle Cell Disease Who Participated in the Study GBT440-001
Clinical trial NCT03041909 · COMPLETED
Trial details
- NCT number
- NCT03041909
- Sponsor
- Global Blood Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-01
- Primary completion
- 2017-06-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.